OraSure Technologies Company Profile

15:45 EST 20th February 2020 | BioPortfolio

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.


220 East First Street
United States of America


Phone: 610-882-1820
Fax: 610-882-1830

News Articles [173 Associated News Articles listed on BioPortfolio]

OraSure announces sale of cryosurgical systems business

OraSure Technologies, a leader in point-of-care diagnostic tests and specimen collection devices, announced the sale of its cryosurgical systems business to CryoConcepts, LP for an aggregate purchase ...

OraSure Technologies Inc. (OSUR) CEO Stephen Tang on Q3 2019 Results - Earnings Call Transcript

OraSure Technologies, Inc. (OSUR) CEO Stephen Tang on Q2 2019 Results - Earnings Call Transcript

Rapid Ebola test by OraSure gains FDA nod

The FDA has approved the OraQuick Ebola Rapid Antigen Test produced by OraSure for presumptive diagnosis of Ebola virus disea -More- 

FDA approves diagnostic test to stop spread of Ebola

OraSure Technologies has seen its OraQuick Ebola Rapid Antigen Test approved for use by the Food and Drug Administration (FDA).

DNA Genotek gets FDA general use approval for Oragene•Dx family of products

OraSure Technologies wholly-owned subsidiary DNA Genotek has secured general use 510(k) clearance from the US Food and Drug Administration (FDA) for its Oragene·Dx family of products. Oragene·Dx has...

Disruptive Technologies in Pharma 2019

20 - 21 January 2020, London, UK. The conference aims to bring together experts of emerging technologies to discover the opportunities with regards to Artificial intelligence, Machine Learning, Inter...

Global AIDS Rapid Test Kit Market Data Survey Report 20152025 [Published by HeyReport] Prices from USD $1275

SummaryThe global AIDS Rapid Test Kit market will reach xxx Million USD in 2020 with CAGR xx% 20202025. The main contents of the report including:Global market size and forecastRegional market size, p...

PubMed Articles [346 Associated PubMed Articles listed on BioPortfolio]

The Price of Substitute Technologies.

Only a small share of new drugs is truly innovative; 85% to 90% of all new health technologies have little or no advantage over existing therapeutic alternatives. Health economic evaluations can be us...

Advanced Medical Care Program for the rapid introduction of health care technologies to the National Health Insurance system in Japan.

Japan's Advanced Medical Care Program (AMCP) seeks to facilitate patient access to promising health care technologies through National Health Insurance (NHI) coverage. This study aimed to examine AMCP...

Factors Influencing the Adoption of Smart Health Technologies for People With Dementia and Their Informal Caregivers: Scoping Review and Design Framework.

Smart Health technologies (s-Health technologies) are being developed to support people with dementia (PwD) and their informal caregivers at home, to improve care and reduce the levels of burden and s...

How many crashes can connected vehicle and automated vehicle technologies prevent: A meta-analysis.

The connected and automated vehicle (CAV) technologies have made great progresses. It has been commonly accepted that CV or AV technologies would reduce human errors in driving and benefit traffic saf...

Horizon Scanning in Health Care: A German Perspective.

 Decision makers in health care act in an area in which expectations increase to make beneficial new technologies available as soon as possible, to protect patients from unsafe or ineffective techno...

Clinical Trials [608 Associated Clinical Trials listed on BioPortfolio]

Community-based Distribution of Oral HIV Self-testing Kits

This cluster randomised trial aims to evaluate the impact of a pilot HIVST intervention of oral HIV self-testing (HIVST) as an option for HIV testing, in addition to the offer of home-base...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Registry for Real-world Experience of Catheter Ablation for Symptomatic Paroxysmal Atrial Fibrillation

The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal Atrial Fibrillation (PAF) ablation radiofrequency (RF) technologies. Data from the registry w...

Companies [1332 Associated Companies listed on BioPortfolio]

OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro ...

Epitope Incorporated

Epitope, Inc. develops and markets oral specimen collection kits and related diagnostic tests primarily for the detection of the Human Immunodeficiency Virus (HIV), the cause of Acquired Immune De...

HealthCare Ventures

HealthCare Ventures is a leading venture capital firm specializing in life science industry investing. At HealthCare Ventures we concentrate our investment dollars on life science companies showing hi...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

More Information about "OraSure Technologies" on BioPortfolio

We have published hundreds of OraSure Technologies news stories on BioPortfolio along with dozens of OraSure Technologies Clinical Trials and PubMed Articles about OraSure Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OraSure Technologies Companies in our database. You can also find out about relevant OraSure Technologies Drugs and Medications on this site too.

Quick Search

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record